Shares of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC – Get Rating) have been assigned an average recommendation of "Hold" from the six brokerages that are currently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $8.10.

Several research firms recently weighed in on TRHC. StockNews.com upgraded Tabula Rasa HealthCare from a "sell" rating to a "hold" rating in a research report on Thursday, October 20th. Piper Sandler lowered their price objective on Tabula Rasa HealthCare from $6.00 to $4.00 and set a "neutral" rating on the stock in a research report on Monday, November 7th.

Insider Buying and Selling

In other news, CFO Thomas Cancro bought 11,500 shares of the firm's stock in a transaction that occurred on Monday, December 12th. The shares were bought at an average cost of $4.34 per share, for a total transaction of $49,910.00. Following the completion of the transaction, the chief financial officer now owns 211,500 shares of the company's stock, valued at $917,910. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Michael J. Purcell sold 10,000 shares of the business's stock in a transaction dated Friday, December 9th. The stock was sold at an average price of $4.26, for a total value of $42,600.00. Following the sale, the director now directly owns 88,514 shares in the company, valued at $377,069.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Thomas Cancro bought 11,500 shares of the firm's stock in a transaction that occurred on Monday, December 12th. The stock was purchased at an average price of $4.34 per share, for a total transaction of $49,910.00. Following the completion of the transaction, the chief financial officer now directly owns 211,500 shares of the company's stock, valued at approximately $917,910. The disclosure for this purchase can be found here. 7.25% of the stock is owned by company insiders.

Institutional Investors Weigh In On Tabula Rasa HealthCare

Tabula Rasa HealthCare Stock Performance

NASDAQ TRHC opened at $6.33 on Wednesday. The company has a market capitalization of $171.69 million, a PE ratio of -1.09 and a beta of 1.58. The business's fifty day moving average is $4.60 and its 200 day moving average is $4.38. Tabula Rasa HealthCare has a fifty-two week low of $2.09 and a fifty-two week high of $13.07.

Tabula Rasa HealthCare (NASDAQ:TRHC – Get Rating) last released its earnings results on Thursday, November 3rd. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.78). The company had revenue of $77.10 million for the quarter, compared to analysts' expectations of $73.68 million. Tabula Rasa HealthCare had a negative net margin of 46.03% and a negative return on equity of 472.90%. On average, sell-side analysts forecast that Tabula Rasa HealthCare will post -2.11 EPS for the current year.

Tabula Rasa HealthCare Company Profile

(Get Rating)

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems.

Recommended Stories

• Get a free copy of the StockNews.com research report on Tabula Rasa HealthCare (TRHC)
• When Will Crane Holdings Take Flight?
• Is It Time To Get Aggressive With Defense Stocks?
• 3 Retail Stocks Ringing the Register in 2023
• Qualcomm Gets a Boost from Analysts, but is it Time to Buy?
• EVgo Stock is Charged Up to Ride the EV Adoption Wave

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.